Țiburcă, L.; Bembea, M.; Zaha, D.C.; Jurca, A.D.; Vesa, C.M.; Rațiu, I.A.; Jurca, C.M.
The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. Curr. Issues Mol. Biol. 2022, 44, 1851-1866.
https://doi.org/10.3390/cimb44050127
AMA Style
Țiburcă L, Bembea M, Zaha DC, Jurca AD, Vesa CM, Rațiu IA, Jurca CM.
The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. Current Issues in Molecular Biology. 2022; 44(5):1851-1866.
https://doi.org/10.3390/cimb44050127
Chicago/Turabian Style
Țiburcă, Laura, Marius Bembea, Dana Carmen Zaha, Alexandru Daniel Jurca, Cosmin Mihai Vesa, Ioana Adela Rațiu, and Claudia Maria Jurca.
2022. "The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases" Current Issues in Molecular Biology 44, no. 5: 1851-1866.
https://doi.org/10.3390/cimb44050127
APA Style
Țiburcă, L., Bembea, M., Zaha, D. C., Jurca, A. D., Vesa, C. M., Rațiu, I. A., & Jurca, C. M.
(2022). The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. Current Issues in Molecular Biology, 44(5), 1851-1866.
https://doi.org/10.3390/cimb44050127
